U.S. markets close in 6 hours 28 minutes

Fusion Pharmaceuticals Inc. (FUSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.88+0.67 (+8.16%)
As of 9:31AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/27/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
340.47M448.58M490.28M500.80M727.87M
Enterprise Value 3
120.77M226.18M198.33M181.91M660.45M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
1.221.521.601.5912.48
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-2.60-12.87-17.05-17.88-92.20

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-39.32%
S&P500 52-Week Change 335.56%
52 Week High 314.31
52 Week Low 36.61
50-Day Moving Average 38.17
200-Day Moving Average 39.79

Share Statistics

Avg Vol (3 month) 368.07k
Avg Vol (10 day) 335.1k
Shares Outstanding 542.93M
Implied Shares Outstanding 6N/A
Float 22.47M
% Held by Insiders 19.05%
% Held by Institutions 180.46%
Shares Short (Jul 14, 2021) 4157.09k
Short Ratio (Jul 14, 2021) 41.17
Short % of Float (Jul 14, 2021) 40.37%
Short % of Shares Outstanding (Jul 14, 2021) 40.37%
Shares Short (prior month Jun 14, 2021) 4239.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-15.82%
Return on Equity (ttm)-50.76%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -46.49M
Net Income Avi to Common (ttm)-85.64M
Diluted EPS (ttm)-2.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)227.22M
Total Cash Per Share (mrq)5.35
Total Debt (mrq)7.52M
Total Debt/Equity (mrq)2.69
Current Ratio (mrq)30.70
Book Value Per Share (mrq)6.67

Cash Flow Statement

Operating Cash Flow (ttm)-42.74M
Levered Free Cash Flow (ttm)-31.35M